User:Patrick Wiencek/AHNAK

From Proteopedia

(Difference between revisions)

Revision as of 06:13, 3 May 2018

AHNAK

This is a default text for your page Patrick Wiencek/AHNAK. Click above on edit this page to modify. Be careful with the < and > signs.

You may include any references to papers as in: the use of JSmol in Proteopedia ^[1] or to the article describing Jmol ^[2] to the rescue.

1 Introduction
2 Structure
- 2.1 The Central Repeated Domain
- 2.2 Protein Interactions and Post-Translational Modifications
3 Function
4 AHNAK in Disease
5 Evolutionarily Related Proteins
6 Links to Available AHNAK Structures
7 Structural highlights

Introduction

AHNAK is a protein characterized by its large size (700 kDa) and its unique tripartite structure ^[1,2]. Originally identified in 1989 as a desmosomal plaque protein purified from bovine muzzle epidermis called desmoyokin, AHNAK is now recognized as a scaffolding protein that has implicated in a wide range of diverse biological processes ^[1,2]. This includes processes from Ca2+ channel regulation and cell adhesion to cell cycle arrest ^[1,3-5]. Despite the diversity of processes that AHNAK is involved in, they’re unified in the formation of multi-protein complexes, AHNAK likely serving as a scaffolding protein for other proteins in the complex ^[1].

In alignment with AHNAK’s many functions, AHNAK has several identified subcellular localizations depending on cell type, intercellular contacts, and the phosphorylation state of the protein ^[1,6]. These include the plasma membrane, the cytoplasm and the nucleus ^[2,7-9]. There is also evidence supporting AHNAK’s export to the extracellular space ^[9].

Structure

AHNAK has a unique structure made up of three main domains: the N-terminal domain, the central repeated domain, and the C-terminal domain (Figure 1). These domains are 251, 4300, and 1002 amino acids in length, respectively ^[1,8].

Figure 1. A structural representation of AHNAK, including sites of protein interaction. Modified from [1]

The Central Repeated Domain

The central repeated domain is comprised of many 128 amino acid repeated elements, these generally being rich in charged residues ^[8]. These elements are highly conserved, on average sharing an identity of 80% and maintaining both polarity and charge in their amino acid substitutions. Underlying the 128-residue repeat is a 7-residue repeat with the pattern: Φ+ΦP+Φ+, where Φ are hydrophobic residues, + are charged residues, and P is a proline residue. A molecular model of the structure resembles that of a β-strand, where intermolecular hydrogen bonding could cause the protein to adopt a seven or eight-stranded barrel structure with a diameter of 9.8 or 10.1 Å, respectively. This results in an polyionic rod structure as long as 1.2 µm.

Protein Interactions and Post-Translational Modifications

AHNAK contains many different sites for protein-protein interactions and post-translational modifications (Figure 1). The UniProt entry for human AHNAK (Q09666) shows 179 sites of post-translational modification distributed across all 3 of AHNAK’s domains. The N-terminal domain of AHNAK contains a PDZ domain ^[10]. PDZ domains are domains involved in protein interaction, typically recognizing short C-terminal amino acid sequences of their target proteins ^[11]. AHNAK has been demonstrated undergoing heterodimerization between its large and small isoforms, likely through interactions with their PDZ domains ^[12]. The small AHNAK isoform is also capable of homodimerization.

AHNAK has many different sites of interaction for the many other proteins and processes that it relates to, below is a list of some of the other molecules and proteins that AHNAK can interact with, a description of the interaction, and the location of the interaction in the AHNAK protein:

Actins

Both F- and G- actin have been shown interacting with residues 5262–5643 of the C-terminal domain of AHNAK ^[13].

Annexin2/S100A10

AHNAK will interact with Annexin2/S100A10 structural scaffolding complex through residues 4642–5643 in its C-terminal domain ^[7].

β2 subunit of L-type voltage-gated calcium (Ca_v) channels

The β2 subunit of Ca_v channels will interact with residues 5262-5643 of the C-terminal domain of AHNAK ^[13].

Calpain 3

There are 5 cleavage sites for Calpain in AHNAK, 2 are in the N-terminus and 3 are in the C-terminus. ^[14]

Dysfurlin

The N-terminal region of dysfurlin will interact with the C-terminal domain of AHNAK from residues 5146 – 5643 ^[15].

DNA

AHNAK has been shown having weak DNA binding affinity similar to the Ku protein 16. Sequence alignment of AHNAK with Ku70 and Ku80 indicated areas of similarity from residues 1-200 and 4661-5260 respectively ^[17]. These sites may be AHNAK’s prospective DNA binding sites.

Protein Kinase B (PKB)

PKB will phosphorylate serine 5535 in AHNAK’s C-terminal domain ^[6]. This will activate AHNAK’s nuclear export signal, allowing it to move out of the nucleus. AHNAK’s nuclear export signal is made up of 5 different motifs in the C-terminal domain: (4971-4979), (5019-5027), (5034-5039), (5706-5716), and (5772-5779) ^[18].

Protein Kinase C α (PKCα)

PKCα will bind to and is activated by AHNAK ^[19]. This interaction occurs in AHNAK’s central repetitive domain (3859-4412).

Phospholipase C γ (PLCγ)

PLCγ will bind AHNAK in its central repetitive domain in residues 3740-3882 and 3859-4412 ^[20]. AHNAK also activated bound PLCγ.

Regulatory Samds (R-Smads)

The MH2 domain of Smad2 will bind to the central repetitive domain of AHNAK from residues 4105-4633 ^[21].

It is also of not that AHNAK does not have a calcium binding domain, despite it responding to calcium signaling. Calcium sensing might be facilitated by AHNAK’s interaction with annexin 2, which is calcium sensitive ^[1,22,23].

Function

AHNAK has a diverse list of biological processes that is has been implicated in, including cell signaling and cell contacts, regulation of calcium channels, membrane repair, and interaction with DNA ligase 1. AHNAK has been implicated in each of these biological processes, each with a description of its role:

Cell signaling

The central repetitive domain of AHNAK has been shown binding and activating the signaling proteins PKCα and PLCγ 19,20. This activation has been demonstrated as having a downstream activating effect on the RAF/MEK/ERK pathway, which in turn regulates gene expression 19,20,24. The central repetitive domain of AHNAK has also been shown to play a role in the TGFβ and Smad signaling pathway 21. AHNAK can interact with and translocate regulatory-Smad proteins 1-3 to the nucleus. This translocation increases the binding of phosphor-Smad3 to the c-Myc promoter, resulting in decreased c-Myc expression and in turn less cell proliferation. AHNAK overexpression in mouse fibroblast cells resulted in an accumulation of cells in the G0 and G1 phases of the cell cycle, indicating cell cycle arrest 21.

Neurogenesis

AHNAK has been associated with several different processes involving neurogenesis. In the peripheral nervous system AHNAK might play a role in myelination 25,26. AHNAK is expressed during the period of laminin deposition and myelination in Schwann cells, and AHNAK knockdown showed detachment from laminin substrates. In the central nervous system AHNAK was implicated in the formation of the blood brain barrier, as endothelial cells forming the blood brain barrier had increased AHNAK expression levels compared to those not forming the blood brain barrier 27. AHNAK null mice displayed increased levels of hippocampal neurogenesis in adult mice, indicating that AHNAK might be involved in modulating the differentiation of new cells to neuronal or non-neuronal cells 28.

Cell-Cell contact formation

In addition to phosphorylation by PKB, AHNAK localization in epithelial cells depends on cell confluency, where sub-confluent cells displayed a nuclear localization while confluent cells displayed a cytoplasmic or plasma membrane localization 6. When AHNAK re-localizes to the plasma membrane it complexes with actin and heterotetrameric annexin2/S100A10 7. A structural analysis of this complex reveals that both annexin2 and S100A10 are necessary for the complex to form 29. A possible mechanism for calcium dependent cell-cell contact formation is that PKB phosphorylation of AHNAK will cause its translocation to the plasma membrane where it complexes with actin and annexin2/S100A10 1,6,7.

Calcium channels

AHNAK can bind the β2 subunit of L-type voltage gated calcium (Cav ) channels in cardiomyocytes 13. AHNAK seems to have different effects on calcium channels and from calcium across the cited studies. This may be due to different calcium channel isoforms, or different cell types (and thus different responses to calcium) 1. One hypothesis of AHNAK function with the β2 subunit is that following β-adrenergic stimulation and phosphorylation of AHNAK by PKA, AHNAK will release the β2 subunit of the Cav channel and allow normal calcium influx 31. AHNAK was also implicated in calcium influx in CD4+ T cells and cytotoxic CD8+ effector T-cells 32,33. Here, AHNAK null mice showed decreased calcium influx, leading experts to hypothesize that the underlying mechanism involved AHNAK assisting the β2-subunit in membrane localization 34.

Membrane repair

AHNAK is involved in the process of membrane repair through its presence in enlargeosomes, vesicles that fuse with the plasma membrane for differentiation and membrane repair 35. AHNAK typically marks these enlargeosomes just below the plasma membrane. When stimulated with ionomycin AHNAK will label the plasma membrane, as would be expected from a membrane fusion event 35. AHNAK co-localizes and interacts with a membrane repair protein dysferlin, which also interacts with the annexin2/S100A10 complex 15,36. AHNAK’s interaction with S100A10 is small enough to allow it to still interact with dysferlin 23,29. This complex may be regulated by calpain 3, a protease that has been implicated in limb girdle muscular dystrophy A2 along with dysferlin and was experimentally shown to cleave AHNAK 14.

Repair of double strand breaks

In 2004, AHNAK was published interacting specifically with the DNA ligase IB-XRCC4 complex, which is involved in non-homologous end joining 16. This interaction is not observed with AHNAK and other DNA ligases. AHNAK was shown having a weak DNA-binding affinity by itself, but formed a more stable complex when complexed with DNA and DNA ligase.

AHNAK in Disease

Despite initial mouse models that showed no phenotypic defects in AHNAK-null mice, AHNAK has been related to several different diseases 10,37. These include but are not limited to: cancer, obesity, and aging 1,38–40.

Cancer

AHNAK’s roles in cancer and tumor metastasis have recently become a large part of the research being done with AHNAK. Due to AHNAK’s implications in many different biological processes, AHNAK seems to promote cancer in some contexts 30,41, and serve as a tumor suppressor in others 3,4,21. Due to its functionality in cytoskeletal stabilization and interaction with actin filaments, AHNAK was found to be essential in actin-rich pseudopod protrusion across several different metastatic human tumor cell lines 30. AHNAK knockdown caused these cells to retract their pseudopods and reverse the epithelial to mesenchymal transition that is necessary for cancer metastasis 30. Similarly, significantly higher levels of AHNAK expression were detected in mesotheliomal cell lines, and migration and invasion were both decreased following AHNAK knockdown 41.

AHNAK can also act as a tumor suppressor because of its role in the TFGβ/Smad pathway 21. Overexpression of AHNAK in mouse fibroblast cell resulted in increased cell-cycle arrest. Analysis of AHNAK mRNA levels in glioma demonstrated that AHNAK was down-regulated in some cell lines, and was a statistically significant prognostic factor for poor survival of glioma patients 4. Similar results were shown in a study of AHNAK in triple-negative breast cancer, also associating AHNAK with the AMK/MAPK signaling pathway and the Wnt/β-catenin pathway 3. These differing effects of AHNAK in cancer may involve its regulation via TGFβ, which has both tumor suppressor and tumor promotor roles 1,42.

Obesity

In a 2010 study, AHNAK knock out mice were found to have a resistance to high-fat diet-induced obesity 43. The authors indicated that the mechanism of resistance likely was related to changes in amino acid levels related to fat metabolism, but did not elucidate a direct mechanism for the effect that they saw. Similarly, impaired adipogenesis has been observed in AHNAK null mice 44. Adipocyte differentiation and adipogenesis relies on the expression of Pparγ2, which in turn relies on Smad signaling. By potentiating Pparγ2 signaling, AHNAK serves as a regulator of metabolic homeostasis and might be useful in future metabolic disorder studies related to obesity 44.

Aging

AHNAK has also been implicated in the aging process. In an analysis of gene expression analysis of human skeletal muscle biopsies, AHNAK displayed increased expression with increased age 38,39. Similarly, in an analysis of gene expression profiles of multiple male age groups, high AHNAK expression levels were correlated with low maximal oxygen uptake and poor muscle fitness 40.

Evolutionarily Related Proteins

AHNAK is ubiquitously expressed in most tissues throughout the body, and the AHNAK family of proteins is specific to vertebrates 9,12,45. There are 3 AHNAK-like genes, AHNAK1, AHNAK2, and Periaxin. AHNAK2 is a 600-kDa protein that is hypothesized to have a similar localization and function to AHNAK 1 10. Periaxin is a 155-kDa protein that is important in the myelination of the peripheral nervous system 46.

All 3 of these proteins have similar genetic structure (several small exons that are upstream of a single large exon), tripartite repeat protein structure, and conserved N-terminal PDZ domain 12. Both AHNAK and Periaxin have large and small isoforms 47. Phylogenetic analysis of the 3 AHNAK family members and their isoforms indicates that the AHNAK protein family is derived from a common ancestor and that Periaxin and AHNAK2 are more similar than AHNAK 12.

AHNAK has previously been reported dimerizing, and the PDZ domains of AHNAK2 and Periaxin have been crystallized as homodimers (sources of AHNAK dimer and PDZ dimerization). This dimerization may be an important piece of the scaffolding functions of the proteins in the AHNAK family 48.

Links to Available AHNAK Structures

AHNAK Structures

4ftg - An AHNAK peptide in complex with the S1—S1-/AnxA2 heterotetramer
4drw - The ternary complex between S1—A1-, an Annexin A2 N-terminal peptide and an AHNAK peptide
4hrg - p11-Annexin A2(N-terminal) Fusion protein complexed with AHNAK1 peptide

AHNAK Homolog Structures

4cn0 - An intertwined homodimer of the PDZ homology domain of AHNAK2
4cmz - An intertwined homodimer of the PDZ homology domain of periaxin

Structural highlights

This is a sample scene created with SAT to by Group, and another to make of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes.

References

1. Davis, T. A., Loos, B. & Engelbrecht, A.-M. AHNAK: the giant jack of all trades. Cell. Signal. 26, 2683–2693 (2014).

2. Hashimoto, T. et al. Desmoyokin, a 680 kDa keratinocyte plasma membrane-associated protein, is homologous to the protein encoded by human gene AHNAK. J. Cell Sci. 105 ( Pt 2), 275–286 (1993).

3. Chen, B. et al. AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer. J. Exp. Clin. Cancer Res. CR 36, 65 (2017).

4. Zhao, Z. et al. AHNAK as a Prognosis Factor Suppresses the Tumor Progression in Glioma. J. Cancer 8, 2924–2932 (2017).

5. Davis, T. et al. Doxorubicin resistance in breast cancer: A novel role for the human protein AHNAK. Biochem. Pharmacol. 148, 174–183 (2018).

6. Sussman, J., Stokoe, D., Ossina, N. & Shtivelman, E. Protein kinase B phosphorylates AHNAK and regulates its subcellular localization. J. Cell Biol. 154, 1019–1030 (2001).

7. Benaud, C. et al. AHNAK interaction with the annexin 2/S100A10 complex regulates cell membrane cytoarchitecture. J. Cell Biol. 164, 133–144 (2004).

8. Shtivelman, E., Cohen, F. E. & Bishop, J. M. A human gene (AHNAK) encoding an unusually large protein with a 1.2-microns polyionic rod structure. Proc. Natl. Acad. Sci. U. S. A. 89, 5472–5476 (1992).

9. Cell atlas - AHNAK - The Human Protein Atlas. Available at: http://www.proteinatlas.org/ENSG00000124942-AHNAK/cell. (Accessed: 30th April 2018)

10. Komuro, A. et al. The AHNAKs are a class of giant propeller-like proteins that associate with calcium channel proteins of cardiomyocytes and other cells. Proc. Natl. Acad. Sci. 101, 4053–4058 (2004).

11. Lee, H.-J. & Zheng, J. J. PDZ domains and their binding partners: structure, specificity, and modification. Cell Commun. Signal. 8, 8 (2010).

12. de Morrée, A. et al. Self-regulated alternative splicing at the AHNAK locus. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 26, 93–103 (2012).

13. Hohaus, A. et al. The carboxyl-terminal region of ahnak provides a link between cardiac L-type Ca2+ channels and the actin-based cytoskeleton. FASEB J. 16, 1205–1216 (2002).

14. Huang, Y. et al. Calpain 3 is a modulator of the dysferlin protein complex in skeletal muscle. Hum. Mol. Genet. 17, 1855–1866 (2008).

15. Huang, Y. et al. AHNAK, a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration. FASEB J. 21, 732–742 (2006).

16. Stiff, T., Shtivelman, E., Jeggo, P. & Kysela, B. AHNAK interacts with the DNA ligase IV-XRCC4 complex and stimulates DNA ligase IV-mediated double-stranded ligation. DNA Repair 3, 245–256 (2004).

17. EMBOSS Needle < Pairwise Sequence Alignment < EMBL-EBI. Available at: https://www.ebi.ac.uk/Tools/psa/emboss_needle/. (Accessed: 2nd May 2018)

18. AHNAK - Neuroblast differentiation-associated protein AHNAK - Homo sapiens (Human) - AHNAK gene & protein. Available at: https://www.uniprot.org/uniprot/Q09666#ptm_processing. (Accessed: 1st May 2018)

19. Lee, I. H. et al. Ahnak Protein Activates Protein Kinase C (PKC) through Dissociation of the PKC-Protein Phosphatase 2A Complex. J. Biol. Chem. 283, 6312–6320 (2008).

20. Sekiya, F., Bae, Y. S., Jhon, D. Y., Hwang, S. C. & Rhee, S. G. AHNAK, a Protein That Binds and Activates Phospholipase C-γ1 in the Presence of Arachidonic Acid. J. Biol. Chem. 274, 13900–13907 (1999).

21. Lee, I. H. et al. Ahnak functions as a tumor suppressor via modulation of TGFβ/Smad signaling pathway. Oncogene 33, 4675–4684 (2014).

22. Grieve, A. G., Moss, S. E. & Hayes, M. J. Annexin A2 at the Interface of Actin and Membrane Dynamics: A Focus on Its Roles in Endocytosis and Cell Polarization. International Journal of Cell Biology (2012). Available at: https://www.hindawi.com/journals/ijcb/2012/852430/. (Accessed: 2nd May 2018)

23. Rezvanpour, A., Santamaria-Kisiel, L. & Shaw, G. S. The S100A10-Annexin A2 Complex Provides a Novel Asymmetric Platform for Membrane Repair. J. Biol. Chem. 286, 40174–40183 (2011).

24. Chang, F. et al. Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention. Leukemia 17, 1263–1293 (2003).

25. Boxberg, Y. V. et al. Spinal cord injury-induced up-regulation of AHNAK, expressed in cells delineating cystic cavities, and associated with neoangiogenesis. Eur. J. Neurosci. 24, 1031–1041 (2006).

26. Salim, C., Boxberg, Y. V., Alterio, J., Féréol, S. & Nothias, F. The giant protein AHNAK involved in morphogenesis and laminin substrate adhesion of myelinating Schwann cells. Glia 57, 535–549 (2009).

27. Gentil, B. J. et al. Specific AHNAK expression in brain endothelial cells with barrier properties. J. Cell. Physiol. 203, 362–371 (2005).

28. Shin, J. H. et al. Increased Cell Proliferations and Neurogenesis in the Hippocampal Dentate Gyrus of Ahnak Deficient Mice. Neurochem. Res. 40, 1457–1462 (2015).

29. Dempsey, B. R. et al. Structure of an Asymmetric Ternary Protein Complex Provides Insight for Membrane Interaction. Structure 20, 1737–1745 (2012).

30. Shankar, J. et al. Pseudopodial Actin Dynamics Control Epithelial-Mesenchymal Transition in Metastatic Cancer Cells. Cancer Res. 70, 3780–3790 (2010).

31. Alvarez, J. et al. Calcium Current in Rat Cardiomyocytes Is Modulated by the Carboxyl-terminal Ahnak Domain. J. Biol. Chem. 279, 12456–12461 (2004).

32. Matza, D. et al. A Scaffold Protein, AHNAK1, Is Required for Calcium Signaling during T Cell Activation. Immunity 28, 64–74 (2008).

33. Matza, D. et al. Requirement for AHNAK1-mediated calcium signaling during T lymphocyte cytolysis. Proc. Natl. Acad. Sci. 106, 9785–9790 (2009).

34. Chien, A. J. et al. Roles of a Membrane-localized βSubunit in the Formation and Targeting of Functional L-type Ca2+ Channels. J. Biol. Chem. 270, 30036–30044 (1995).

35. Borgonovo, B. et al. Regulated exocytosis: a novel, widely expressed system. Nat. Cell Biol. 4, 955–963 (2002).

36. Lennon, N. J. et al. Dysferlin Interacts with Annexins A1 and A2 and Mediates Sarcolemmal Wound-healing. J. Biol. Chem. 278, 50466–50473 (2003).

37. Kouno, M. et al. Ahnak/Desmoyokin Is Dispensable for Proliferation, Differentiation, and Maintenance of Integrity in Mouse Epidermis. J. Invest. Dermatol. 123, 700–707 (2004).

38. Su, J. et al. A novel atlas of gene expression in human skeletal muscle reveals molecular changes associated with aging. Skelet. Muscle 5, 35 (2015).

39. de Magalhães, J. P., Curado, J. & Church, G. M. Meta-analysis of age-related gene expression profiles identifies common signatures of aging. Bioinforma. Oxf. Engl. 25, 875–881 (2009).

40. Parikh, H. et al. Molecular correlates for maximal oxygen uptake and type 1 fibers. Am. J. Physiol.-Endocrinol. Metab. 294, E1152–E1159 (2008).

41. Sudo, H. et al. AHNAK is highly expressed and plays a key role in cell migration and invasion in mesothelioma. Int. J. Oncol. 44, 530–538 (2014).

42. Heldin, C.-H., Landström, M. & Moustakas, A. Mechanism of TGF-β signaling to growth arrest, apoptosis, and epithelial–mesenchymal transition. Curr. Opin. Cell Biol. 21, 166–176 (2009).

43. Kim, I. Y. et al. 1H NMR-based metabolomic study on resistance to diet-induced obesity in AHNAK knock-out mice. Biochem. Biophys. Res. Commun. 403, 428–434 (2010).

44. Shin, J. H. et al. Obesity Resistance and Enhanced Insulin Sensitivity in Ahnak -/- Mice Fed a High Fat Diet Are Related to Impaired Adipogenesis and Increased Energy Expenditure. PLoS ONE 10, (2015).

45. AceView: Gene:AHNAK, a comprehensive annotation of human, mouse and worm genes with mRNAs or ESTsAceView. Available at: https://www.ncbi.nlm.nih.gov/IEB/Research/Acembly/av.cgi?db=human&c=Gene&l=AHNAK. (Accessed: 30th April 2018)

46. Gillespie, C. S., Sherman, D. L., Blair, G. E. & Brophy, P. J. Periaxin, a novel protein of myelinating Schwann cells with a possible role in axonal ensheathment. Neuron 12, 497–508 (1994).

47. Dytrych, L., Sherman, D. L., Gillespie, C. S. & Brophy, P. J. Two PDZ Domain Proteins Encoded by the Murine Periaxin Gene Are the Result of Alternative Intron Retention and Are Differentially Targeted in Schwann Cells. J. Biol. Chem. 273, 5794–5800 (1998).

48. Han, H. & Kursula, P. Periaxin and AHNAK nucleoprotein 2 form intertwined homodimers through domain swapping. J. Biol. Chem. 289, 14121–14131 (2014).

↑ Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
↑ Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644

Proteopedia Page Contributors and Editors (what is this?)

Patrick Wiencek

Retrieved from "http://52.214.119.220/wiki/index.php/User:Patrick_Wiencek/AHNAK"

@@ Line 24: / Line 24: @@
 === Protein Interactions and Post-Translational Modifications ===
-AHNAK contains many different sites for protein-protein interactions and post-translational modifications (Figure 1). The UniProt entry for human AHNAK (Q09666) shows 179 sites of post-translational modification distributed across all 3 of AHNAK’s domains. The N-terminal domain of AHNAK contains a PDZ domain 10. PDZ domains are domains involved in protein interaction, typically recognizing short C-terminal amino acid sequences of their target proteins 11. AHNAK has been demonstrated undergoing heterodimerization between its large and small isoforms, likely through interactions with their PDZ domains 12. The small AHNAK isoform is also capable of homodimerization.
+AHNAK contains many different sites for protein-protein interactions and post-translational modifications (Figure 1). The UniProt entry for human AHNAK (Q09666) shows 179 sites of post-translational modification distributed across all 3 of AHNAK’s domains. The N-terminal domain of AHNAK contains a PDZ domain <sup>[10]</sup>. PDZ domains are domains involved in protein interaction, typically recognizing short C-terminal amino acid sequences of their target proteins <sup>[11]</sup>. AHNAK has been demonstrated undergoing heterodimerization between its large and small isoforms, likely through interactions with their PDZ domains <sup>[12]</sup>. The small AHNAK isoform is also capable of homodimerization.
 AHNAK has many different sites of interaction for the many other proteins and processes that it relates to, below is a list of some of the other molecules and proteins that AHNAK can interact with, a description of the interaction, and the location of the interaction in the AHNAK protein:
 *'''Actins'''
-Both F- and G- actin have been shown interacting with residues 5262–5643 of the C-terminal domain of AHNAK 13.
+Both F- and G- actin have been shown interacting with residues 5262–5643 of the C-terminal domain of AHNAK <sup>[13]</sup>.
 *'''Annexin2/S100A10'''
-AHNAK will interact with Annexin2/S100A10 structural scaffolding complex through residues  4642–5643 in its C-terminal domain 7.
+AHNAK will interact with Annexin2/S100A10 structural scaffolding complex through residues  4642–5643 in its C-terminal domain <sup>[7]</sup>.
 *'''β2 subunit of L-type voltage-gated calcium (Ca<sub>v</sub>) channels'''
-The β2 subunit of Ca<sub>v</sub> channels will interact with residues 5262-5643 of the C-terminal domain of AHNAK 13.
+The β2 subunit of Ca<sub>v</sub> channels will interact with residues 5262-5643 of the C-terminal domain of AHNAK <sup>[13]</sup>.
 *'''Calpain 3'''
-There are 5 cleavage sites for Calpain in AHNAK, 2 are in the N-terminus and 3 are in the C-terminus. 14
+There are 5 cleavage sites for Calpain in AHNAK, 2 are in the N-terminus and 3 are in the C-terminus. <sup>[14]</sup>
 *'''Dysfurlin'''
-The N-terminal region of dysfurlin will interact with the C-terminal domain of AHNAK from residues 5146 – 5643 15.
+The N-terminal region of dysfurlin will interact with the C-terminal domain of AHNAK from residues 5146 – 5643 <sup>[15]</sup>.
 *'''DNA'''
-AHNAK has been shown having weak DNA binding affinity similar to the Ku protein 16. Sequence alignment of AHNAK with Ku70 and Ku80 indicated areas of similarity from residues 1-200 and 4661-5260 respectively 17. These sites may be AHNAK’s prospective DNA binding sites.
+AHNAK has been shown having weak DNA binding affinity similar to the Ku protein 16. Sequence alignment of AHNAK with Ku70 and Ku80 indicated areas of similarity from residues 1-200 and 4661-5260 respectively <sup>[17]</sup>. These sites may be AHNAK’s prospective DNA binding sites.
 *'''Protein Kinase B (PKB)'''
-PKB will phosphorylate serine 5535 in AHNAK’s C-terminal domain 6. This will activate AHNAK’s nuclear export signal, allowing it to move out of the nucleus. AHNAK’s nuclear export signal is made up of 5 different motifs in the C-terminal domain:  (4971-4979), (5019-5027), (5034-5039), (5706-5716), and (5772-5779) 18.
+PKB will phosphorylate serine 5535 in AHNAK’s C-terminal domain <sup>[6]</sup>. This will activate AHNAK’s nuclear export signal, allowing it to move out of the nucleus. AHNAK’s nuclear export signal is made up of 5 different motifs in the C-terminal domain:  (4971-4979), (5019-5027), (5034-5039), (5706-5716), and (5772-5779) <sup>[18]</sup>.
 *'''Protein Kinase C α (PKCα)'''
-PKCα will bind to and is activated by AHNAK 19. This interaction occurs in AHNAK’s central repetitive domain (3859-4412).
+PKCα will bind to and is activated by AHNAK <sup>[19]</sup>. This interaction occurs in AHNAK’s central repetitive domain (3859-4412).
 *'''Phospholipase C γ (PLCγ)'''
-PLCγ will bind AHNAK in its central repetitive domain in residues 3740-3882 and 3859-4412 20. AHNAK also activated bound PLCγ.
+PLCγ will bind AHNAK in its central repetitive domain in residues 3740-3882 and 3859-4412 <sup>[20]</sup>. AHNAK also activated bound PLCγ.
 *'''Regulatory Samds (R-Smads)'''
-The MH2 domain of Smad2 will bind to the central repetitive domain of AHNAK from residues 4105-4633 21.
+The MH2 domain of Smad2 will bind to the central repetitive domain of AHNAK from residues 4105-4633 <sup>[21]</sup>.
-It is also of not that AHNAK does not have a calcium binding domain, despite it responding to calcium signaling. Calcium sensing might be facilitated by AHNAK’s interaction with annexin 2, which is calcium sensitive 1,22,23.
+It is also of not that AHNAK does not have a calcium binding domain, despite it responding to calcium signaling. Calcium sensing might be facilitated by AHNAK’s interaction with annexin 2, which is calcium sensitive <sup>[1,22,23]</sup>.
 == '''Function''' ==